The National Medicines Agency (AEO) announced today (18.06.2025) that he recalls specific lots drug that do not meet the specifications for a specific type of cancer in the eye.
The AEO has decided to revoke the batches of the Kimmtrak C/S.Sol.in 100mcg/0.5ml. (Code 3321901) due to out -of -product results when checking the product test tests.
According to the European Medicines Agency (EMA), this medicinal product is used to treat adults with a type of eye cancer called “rosele melanoma”.
It is used when the melanoma of the rave tunic cannot be surgically removed or has spread to other parts of the body.
The Organization’s decision is a precautionary measure to enhance the voluntary revocation to which the company has already made. The lots of the recovery are: 3D009AA04, 3D009AA16, 3D009AA31, and 3D009AA39.
Medison Pharma Mon. AE, he must communicate directly with his recipients and withdraw these lots from the market.
The recall documents must be observed for at least five (5) years and put into account of the AEO if requested.